En casos de alteraciones severas de las paredes estomacales acompa adas de v mitos y diarrea, no est indicado el uso oral de UNASYN oral ya que no se garantiza una absorci n suficiente. En infantes con diarreas recidivantes, no debe usarse UNASYN oral, con excepci n de una introducci n corta de tratamiento parenteral con UNASYN .
To reduce the development of drug-resistant bacteria and maintain the effectiveness of UNASYN and other antibacterial drugs, UNASYN should be used only to
(Unasyn) Dicloxacillin (Dynapen, Dycill) TETRACYCLINES Doxycycline 200–400 mg PO bid (equivalent to 125–250 mg tid); ↓ in renal impair Caution
Intravenous treatment was given for 48 hours then followed by oral Augmentin (amoxicillin/clavulanate) in the Unasyn group, or oral clindamycin in the
Amoxicillin/Clavulanate (Augmentin); Ampicillin/Sulbactam (Unasyn) Cefdinir (Omnicef) - oral; Cefixime (Suprax) - oral; Ceftazidime
Amoxicillin/Clavulanate (Augmentin); Ampicillin/Sulbactam (Unasyn) Cefdinir (Omnicef) - oral; Cefixime (Suprax) - oral; Ceftazidime
(Zosyn, Pfizer), aztreonam or carbapenems if they suspect a polymicrobial Unasyn is only available for parenteral treatment and the closest oral
Vials containing 1.5 g (NDC ) equivalent of UNASYN (1 g ampicillin as the sodium salt plus 0.5 g sulbactam as the sodium salt). Vials containing
Ampicillin-sulbactam (Unasyn) Ampicillin-sulbactam (Unasyn) is the combination of aminopenicillin ampicillin plus beta-lactamase inhibitor sulbactam Has
Comments